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Introduction: What Kills Children?
In a report released in September 2013, the United Nations Children’s 
Fund (UNICEF), together with the World Health Organization
World Bank identified substantial progress in reducing the number of 
children who die before their fi
between 1990 and 201
decreased from 12.6 million to 6.6 million
with approximately one
countries – three in Asia, India, Pakistan and China, and two in Sub
Saharan Africa, Democratic Republic of Congo and Nigeria.
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United Nations Inter-agency Group for Child Mortality Estimation (IGME), Levels and 
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a partnership of WHO, UNICEF, World Bank, the Bill & Melinda Gates 
Foundation, donor governments, developing countries, and international 
finance agencies, which was launched in January 2000 in order to fund 
vaccines for children in the world’s 70 poorest countries.3 Approximately 
2.5 million children’s lives may be saved annually through these activities.2  
If we look at what still kills under-five children today, mostly in developing 
countries in Sub-Saharan Africa, South and Southeast Asia, and a few of 
the poorest Latin American countries (Figure 2), almost one-half of the 
deaths occurs during the neonatal period (first 28 days of life) especially 
from pre-term birth and intrapartum-related complications. However, 
approximately 1.5 million children still die (before their fifth birthday) 
annually from vaccine-preventable diseases.2 In response, in 2010 the Bill 
& Melinda Gates Foundation helped to launch the Decade of Vaccine 
(DoV) collaboration to expand political commitment for the use of vaccines 
and financing of immunization services, creating market incentives to 
ensure a reliable supply of affordable vaccines, and fostering a scientific 
infrastructure for producing vaccines that target high priority diseases.2 
Such activities are expected to produce important additional gains in the 
reduction in childhood deaths.  
Figure 2. Global map of under-five childhood mortality rates in 2012, UNICEF analysis 
based on the United Nations Inter-agency Group for Child Mortality Estimation (IGME), 
Levels and Trends in Child Mortality: Report 2013, UNICEF, New York, 2013. (note: this 
map is stylized and not to scale. It does not reflect a position by UN IGME agencies on 
the legal status of any country or territory or the delimitation of any frontiers.) 
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Lagging Behind: The Pediatric Tropical Diseases 
In contrast to the gains resulting from the GAVI Alliance and the DoV, with 
a few exceptions the overall prevalence of the leading tropical diseases of 
children such as dengue, malaria, schistosomiasis, soil-transmitted 
helminth infections, trachoma, and visceral leishmaniasis has not 
substantially decreased over the last twenty years, and in some cases 
may even be increasing. Shown in Table 1 are the major pediatric tropical 
infections ranked by the estimated number of cases, together with the 
number of deaths that result from these conditions and the number of 
disability-adjusted life years (DALYs), a metric that considers both the 
number of years of life lost from premature death and years lost through 
disability.4-12 DALYs are an important metric for pediatric tropical diseases 
because many of them are not major killers, so much as important 
disablers affecting child development, fitness, future intelligence, and 
wage earning. Below Table 1 is a brief summary of the major pediatric 
tropical diseases.  
Table 1. Leading Tropical Infections that Disproportionately Affect Children Ranked by 
number of estimated cases, DALYs, Deaths 
Disease Estimated 
no. cases 
   DALYs    Deaths Reference 
Soil-transmitted 
helminth infections 
890 million   5.2 million      2,700 5-8 
Dengue 390 million   0.8 million     14,700 5-7, 9 
Malaria 216 million 82.7 million 655,000-
1,169,500 
5-7, 10 
Schistosomiasis 207 million   3.3 million     11,700 5-7, 11 
Trachoma   21 million   0.3 million              0 5-7, 12 
Visceral 
leishmaniasis 
0.2-0.4 million   3.3 million     51,600 5-7, 13 
Total 1.7 billion 95.6 million 735,700-
1,250,200 
 
*With the exception of the children who require treatment for soil-transmitted 
helminth infections these numbers reflect both adults and children although 
children account for majority of the disease burden.  
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 Soil-transmitted helminth (STH) infections. STH infections 
include ascariasis – roundworm infection, trichuriasis – whipworm 
infection, and hookworm infection. Although they are not killer diseases, 
these intestinal nematode infections disproportionately affect preschool 
and school-aged children, leading to growth stunting and intellectual and 
cognitive delays,  and even reductions in future economic potential.7,13-16 
The WHO currently estimates that more than 800 million children, a large 
percentage of children in developing countries, require annual 
anthelminthic treatments – deworming.7 STH infections are widely 
prevalent wherever rural poverty intersects tropical climates in Africa, 
South and Southeast Asia, and Latin America.13  
Dengue. Dengue fever is a flavivirus infection transmitted by Aedes 
mosquitoes that causes high fever, headache, rash, and joint pain, and in 
severe cases leads to hemorrhage, shock, and death.16 Children tend to 
suffer from the greatest morbidity and mortality.16 There has been a huge 
increase in the number of dengue cases annually, with new estimates 
indicating that as many as 390 million cases occur. Among the factors 
contributing to the emergence of dengue are urbanization, environmental 
degradation, lack of mosquito control, increased air travel, and possibly 
climate change.8,16 India and South Asia, the Pacific islands, and coastal 
Latin America, including Brazil and Central America, are currently 
experiencing some of the largest outbreaks of dengue.  
Malaria. Malaria is a parasitic protozoan infection transmitted by 
Anopheles mosquitoes. It remains one of the great childhood killers, 
especially among children between the ages of six months and five 
years.9,17 An estimated 216 malaria infections occur annually, and 
between 655,000 and 1.2 million people die annually from malaria, most of 
it caused by one species Plasmodium falciparum, with most of the deaths 
among children in Sub-Saharan Africa and India.5,9  
Schistosomaisis. Schistosomaisis is another helminth infection 
caused by blood flukes (schistosomes) that frequently occurs together 
with STH infections in children.10,18 Both STH infections and 
schistosomiasis result in childhood growth delays, but schistosomiasis 
also produces severe pathology to the urogenital tract and liver and 
intestines.18 It has been estimated that 207 million cases occur annually 
with about 90% of the cases in Africa10; however, other investigators have 
suggested that the actual number could be much higher such that 
schistosomiasis ranks with STH infections as the most common tropical 
diseases.18  
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Trachoma. Trachoma is a chronic ocular infection caused by the 
intracellular bacteria Chlamydia trachomitis. It is a leading cause of 
blindness in low-income countries, especially in poor rural areas of Africa, 
Asia, and Central and South America, Australia, and the Middle East.11,19 
It is especially common in preschool children in areas where the infection 
is hyperendemic.19 Approximately 21 million cases occur worldwide, of 
whom 2 million are visually impaired and one million are blind.19  
Visceral Leishmaniasis (VL). VL is a systemic illness that affects 
the liver, spleen, and bone marrow (reticuloendothelial system) and is 
caused by parasitic intracellular protozoa of the genus Leishmania. 
Between 0.2 and 0.4 million cases of VL occur worldwide, but most of the 
new cases now occur in India (especially in Bihar State), Bangladesh, 
Sudan and South Sudan, Ethiopia, and Brazil.12 The disease is associated 
with a high mortality unless treated promptly.  
  
Assessing the toll 
Overall, these six tropical infections exert a huge impact on child health, 
including more than 1.7 billion infections, almost 100 million DALYs, and 
between 700,000 and 1.2 million deaths. To put some of these numbers in 
perspective, the tropical diseases that disproportionately affect children 
cause more DALYs than HIV/AIDS,5 and account for more than 10% of all 
childhood deaths. Moreover, it is common for a child to be affected by 
multiple tropical diseases at the same time. For instance, soil-transmitted 
helminth and schistosomiasis co-infections are common, as are these 
infections together with malaria or trachoma.20 Dengue and malaria co-
infections also occur.21   
Even beyond the terrible health toll from tropical infections in 
childhood in terms of DALYs and deaths there is a potentially large 
socioeconomic impact. There is increasing recognition that poverty is an 
overriding determinant for these tropical diseases, and that these 
infections actually cause poverty.22 Malaria was a key factor in thwarting 
economic growth in southern Europe during the mid-twentieth century,23 
while today STH infections, schistosomiasis, trachoma, VL, and dengue 
are holding back the economic development of Africa and Asia.15,18,24-27 
However, we are still at a relatively nascent stage of assigning specific 
dollars lost annually from tropical infections, and there is not yet detailed 
information on exactly how tropical diseases cause economic losses. 
Major factors include losses in agricultural productivity, deficits in child 
intellect and cognition, hospital and health care costs, and maternal 
illness.22 Thus, while we call the six childhood infections “tropical,” they 
are first and foremost diseases of extreme poverty.  
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Consistent with the links between pediatric tropical infections and 
poverty is a recent finding that many of the world’s tropical infections occur 
mostly among the extreme poor living in emerging economies of the group 
of 20 nations.28 Of the 1.2 billion of the world’s poorest people living below 
the World Bank poverty line of $1.25 per day,29 approximately 50% live in 
G20 countries, led by India, China, Indonesia, and Brazil. Together these 
three countries account for more than 600 million people living in extreme 
poverty. Thus tropical infections such as VL, STH infections, lymphatic 
filariasis, food-borne trematodiases, leprosy, Chagas disease, and dengue 
disproportionately occur among the poor in G20 countries.29  
 
Pediatric tropical diseases in the United States 
To emphasize even further the poverty links is an emerging story of 
tropical diseases among the poor in the southern United States. More than 
16 million children in the US (22% of all children) live in families living 
below the federal poverty level,30 with approximately one-fifth of those 
children in rural poverty.31 Of particular concern is the finding by the 
University of Michigan National Poverty Center that 1.65 million 
households with 3.55 million children live on less than $2 per person per 
day in a given month.32 Thus sporadic pockets of poverty in the US 
approach levels seen in developing countries. As shown in Figure 3, the 
US ranks near the bottom of industrialized countries in terms of child 
poverty rates.33 
 
Figure 3. Relative child poverty among industrialized nations by percentage. Map 
created using data from Unicef Inocenti Research Centre Report Card 10, Measuring 
Child Poverty.
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Child poverty in the US is not evenly distributed; it 
disproportionately occurs in the southern states and among people of 
color, especially non-Hispanic black and Hispanic children.34  We 
Identified several neglected tropical diseases  affecting impoverished 
children in the Southern U.S., including parasitic infections such as 
toxocariasis, a larval helminth infection linked to pulmonary and 
neurological deficits and pathologies. 35-39 Other parasitic infections 
associated with child poverty include toxoplasmosis and cysticercosis, 
while impoverished adults were affected by trichomoniasis and Chagas 
disease.35 A key tropical viral infection now found in the southern US is 
dengue, which is linked to poverty in South Texas,35,40 while West Nile 
virus infection is associated with homelessness in Texas.41 Indeed, 
probably the highest prevalence of these tropical infections occurs in 
Texas, where transmission of most of these diseases occurs (as opposed 
to importation through immigration).42 So far two economic analyses of 
tropical infections in the US have been conducted.43,44 The total costs of 
Chagas disease in the US approach $900 million annually,43 while since 
2002 West Nile virus infection cost $112 million in Texas alone.44  
 
Combating tropical infections through disease control and 
prevention 
There is not a unified global alliance to combat all the major tropical 
diseases of children, but there are pockets of success. One of the most 
promising enterprises for tropical disease control has been launched 
through joint efforts supported by the governments of the US and United 
Kingdom through their major overseas development organizations. Both 
governments are providing financial support to health ministries in Africa 
and elsewhere to implement mass treatments using packages of essential 
medicines that target several tropical infections affecting children, 
including the STH infections, schistosomiasis, and trachoma, in addition 
two parasitic infections of adults – lymphatic filariasis and 
onchocerciasis.45,46 These treatments can be administered for only $0.50 
per year, so that it is incredibly inexpensive and possibly as cost-effective 
as vaccines, and is leading to the elimination of lymphatic filariasis, 
onchocerciasis, and trachoma, while reducing the burden of disease from 
STH infections and schistosomiasis.47 Currently effective programs for 
large-scale control of dengue and VL are not in place. For malaria, 
increased vector control and widespread implementation of insecticide 
treated bednets and artemisinin combinations, in parallel with 
strengthening of health systems and improved case management is 
leading to reductions in malaria among young children and pregnant 
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women.18 Four countries have been certified as malaria-free in the past 
five years – Armenia, Morocco, Turkmenistan, and the UAE, and 34 
countries have been identified as “malaria-eliminating” where the number 
of cases overall has decreased by 85% between 2000 to 2010.18 
According to some investigators these international efforts have shifted 
the global malaria disease burden away from younger children to older 
children and adults, especially adult males.18 Such efforts are also shifting 
the malaria burden to migrant populations, with high levels of Plasmodium 
vivax infections.18 In parallel to these control and elimination activities 
international efforts are in place to conduct research and development on 
new tropical disease vaccines, with vaccines for hookworm infection, 
schistosomiasis, and malaria in clinical trials.47 However, vaccines are not 
widely incorporated yet into global elimination strategies alongside mass 
drug treatments and bednets.  
Finally, in the US there is not yet widespread acknowledgement or 
recognition of the tropical disease problem in the southern part of the 
country. Ironically, we are further ahead of tropical disease control and 
elimination efforts internationally than we are for the US.42,48  
While some important successes have been achieved in terms of 
scaling up mass drug administration for childhood helminth infections, ie, 
STH infections and schistosomiasis, and advancing malaria elimination in 
some countries, there is not yet in place an overarching policy that fully 
integrates all of the major pediatric tropical diseases. Yet, in Africa, Asia, 
and elsewhere there is enormous geographic overlap between the 
childhood helminth infections and trachoma with the vector-borne tropical 
diseases such as dengue and malaria. Beyond geographic overlap, co-
infections with helminthiases and vector-borne tropical diseases are 
common, in some cases leading to additive or possibly even synergistic 
morbidities. Therefore, a focused international effort should be 
implemented to identify both theoretical and operational mechanisms that 
link prevention efforts for all of the major pediatric tropical diseases and, 
ultimately, for integrating global control and elimination for these 
conditions. A series of stakeholder meetings led by the WHO and their 
regional offices would represent an important first step for global 
integration of pediatric tropical disease control. Simultaneously, we 
urgently need a policy for scaling up surveillance efforts for tropical 
diseases in southern US, and implementing a new policy for these 
diseases.  
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